Redeye states that the report aligns with preannounced figures and is slightly below RRe on net sale...
Redeye provides a brief comment on Artificial Solutions' Q1 2024 report, which closely aligns with o...
We lower '24e-'26e adj. EBITA by 35-1% Potential for utilisation improvement in H2'24 '24e-'25e EV/E...
Adj. EBITA SEK 27.3m (-1% vs. ABGSCe 27.6m) Q1 numbers imply no material estimate revisions Trading ...
Sales -5%, adj. EBIT +16% vs. ABGSCe, +5% org. sales Guides for Q2 sales growth of ~11%, could lift ...
Doro deliveres weaker topline growth of -7% with a Ebit margin of 2%.
Historiskt starkt Q1 understryker Nordamerikamomentum och ökade volymer för i5 Omsättningen för Q1 u...
Bra leveranser, högre försäljningspriser, men kraftigt fall i produktionen Q1-resultatet påverkades ...
Redeye upgrades its base case and forecasts following a solid Q1 report from Stille.
Redeye has updated its estimates for Safeture following the Q1 2024 report.
Redeye updated its fair value range because of CLS’ reverse share split, where 200 existing shares h...
Sintercast redovisade en positiv start på året och dubblade kassaflödet i kvartalet.
Redeye states that Q1 beat estimates across the board.
Redeye retains its positive view of Sdiptech following a Q1 report that was stronger than our expect...
Redeye’s view on the Q1 report. The organic growth was decent, while the gross margin development co...
Redeye is making some downward adjustments to our financial forecasts, following the Q1 report and a...
Consti’s Q1 net sales beat our estimates slightly while operative profitability missed by only a sma...
Redeye initiates coverage of Precise Biometrics, a global leader in the fingerprint algorithms space...
Redeye takes a positive stance towards Fortnox following an overall solid Q1 report and the negative...
Q1: growth recovery and margin improvements with solid FCF We tweak our '24e sales and adj.
